List of insiders holdings for Taysha Gene Therapies Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Manning Paul B 10% Owner | 2024-07-01 08:00:07 | 1,333,333 23,517,778 | 24,851,111 | Form 4 |
| Session R.A. II 10% Owner | 2023-07-14 16:00:39 | 8,871,747 282,180 | 9,153,927 | Form 4 |
| Audentes Therapeutics Inc. Astellas Pharma Inc. 10% Owner | 2023-08-18 17:16:27 | 7,266,342 0 | 7,266,342 | Form 13D |
| Nolan Sean P. Chief Executive Officer | 2024-01-04 16:41:35 | 2,370,546 1,535,545 | 3,906,091 | Form 4 |
| Stalfort John A III Director | 2024-05-31 16:18:25 | 1,197,041 884,290 | 2,081,331 | Form 4 |
| Nagendran Sukumar President and Head of R&D | 2024-01-04 16:42:30 | 1,761,460 0 | 1,761,460 | Form 4 |
| Alam Kamran CHIEF FINANCIAL OFFICER | 2024-02-06 16:42:03 | 840,937 0 | 840,937 | Form 4 |
| PRASAD SUYASH CMO and Head of R&D | 2022-07-07 16:30:28 | 530,589 0 | 530,589 | Form 4 |
| Donenberg Phillip B. Director | 2024-05-31 16:18:21 | 261,771 0 | 261,771 | Form 4 |
| Sepp-Lorenzino Laura Director | 2024-05-31 16:15:09 | 147,660 0 | 147,660 | Form 4 |
| Long Alison S Director | 2024-05-31 16:18:23 | 147,660 0 | 147,660 | Form 4 |
| Reape Kathleen Director | 2023-06-26 16:50:09 | 36,200 0 | 36,200 | Form 4 |